These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32198017)

  • 21. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal fluence rate of photodynamic therapy for chronic central serous chorioretinopathy.
    Park DG; Jeong S; Noh D; Sagong M
    Br J Ophthalmol; 2021 Jun; 105(6):844-849. PubMed ID: 32727733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Esen E; Sizmaz S; Demircan N
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102347. PubMed ID: 34033938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Noh SR; Kang MS; Kim K; Kim ES; Yu SY
    Korean J Ophthalmol; 2019 Dec; 33(6):506-513. PubMed ID: 31833247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
    Pryds A; Larsen M
    Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
    Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Assessment of Retinal Capillary Vessel Density and Foveal Avascular Zone Area in Central Serous Chorioretinopathy Using OCTA.
    Mao J; Lin J; Zhu L; Liu C; Yu X; Zhang C; Chen Y; Zhang Y; Shen L
    Ophthalmologica; 2020; 243(5):370-378. PubMed ID: 31962342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of an additional photodynamic therapy session after multiple failed PDT treatments in chronic central serous chorioretinopathy.
    Moreno-Morillo FJ; Fernández-Vigo JI; Burgos-Blasco B; Moriche-Carretero M; López-Guajardo L; Donate-López J
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():102953. PubMed ID: 35690322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.
    Kang NH; Kim YT
    Eye (Lond); 2013 Mar; 27(3):387-91. PubMed ID: 23288136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RETROSPECTIVE ANALYSIS OF THE PRESENCE OF CHOROIDAL NEOVASCULARISATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH THE AID OF PHOTODYNAMIC THERAPY.
    Myslík Manethová K; Ernest J
    Cesk Slov Oftalmol; 2021; 77(3):122-131. PubMed ID: 35130703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y; Li L; Xu G; Wang W
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Hagen S; Glittenberg C; Krebs I; Binder S
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Early and Late Morphological and Functional Changes After Verteporfin Photodynamic Therapy.
    Iacono P; Tedeschi M; Boccassini B; Chiaravalloti A; Varano M; Parravano M
    Retina; 2019 May; 39(5):980-987. PubMed ID: 29346241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Evaluation of Retinal Vessel Density in Central Serous Chorioretinopathy after Half-dose Photodynamic Therapy.
    Xu F; Zhou L; Lai K; Gong Y; Li L; Lian P; Huang C; Ding X; Lu L; Jin C
    Curr Eye Res; 2021 Jun; 46(6):855-864. PubMed ID: 33141608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
    Xu Y; Su Y; Li L; Qi H; Zheng H; Chen C
    Ophthalmologica; 2017; 237(3):167-172. PubMed ID: 28171871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological and Functional Changes Immediately After Half-Time Photodynamic Therapy in Patients With Central Serous Chorioretinopathy.
    Muslubas IS; Ersoz MG; Hocaoglu M; Arf S; Karacorlu M
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):932-940. PubMed ID: 30566700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK; Chang CK; Peng CH
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of macular capillary perfusion in patients with inactive Vogt-Koyanagi-Harada disease: an optical coherence tomography angiography study.
    Karaca I; Yılmaz SG; Afrashi F; Nalçacı S
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1181-1190. PubMed ID: 32363500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.